Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era.

Diabetes technology & therapeutics

Volumn 13 Suppl 1, Issue , 2011, Pages

  Bolli, Geremia B ^a   Andreoli, Anna Marinelli ^b   Lucidi, Paola ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; LONG ACTING INSULIN;

DOSE RESPONSE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN, LONG-ACTING;

EID: 80054081129     PISSN: None     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0039     Document Type: Review

References (0)